Association studies have identified the interleukin-1 receptor antagonist gene allele 2(IL-1RNn2) as a marker of susceptibility in ulcerative colitis (UC). This study investigated the significance of the IL-1RN genotype with respect to protein and mRNA expression in the colonic mucosa. Homogenates of rectal biopsies from 99 UC and 54 controls were assayed for cytokines IL1ra, IL-1a and IL-1b using ELISA. IL1RN, IL1A and IL1B genotypes were determined using restriction-enzyme analysis. The ability of the two IL1RN alleles to generate steady-state mRNA accumulation was assessed in the colonic mucosa of seven heterozygous patients. Stepwise linear regression demonstrated that IL-1RN genotype (P¼0.001), diagnosis (Po0.0001) and treatment (Po0.03) were independent factors associated with the IL-1ra protein level whilst IL1RN genotype (P¼0.005) and macroscopic inflammatory grade (Po0.0001) were associated with the IL-1ra/ total IL-1 ratio. The IL1RNn2 correlated with reduced IL-1ra and IL-1ra/IL-1 ratio with a gene dosage effect. In heterozygous UC patients the ratio of allele 1 mRNA / allele 2 steady state mRNA was always greater than 1 (range: 1.2-3.1) (P¼0.018). The IL-1RNn2 is associated with reduced levels of IL-1ra protein and IL-1RN mRNA in the colonic mucosa, providing a biologically plausible explanation for the observed association of the allele with the disease.
Introduction
The causes of the chronic idiopathic inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's disease (CD), remain unknown. Evidence suggests however that disease susceptibility and severity are determined at least in part, by genetic factors. 1 Recent epidemiological data, including family studies, 2 twin studies 3 and investigations in different ethnic populations, 4 suggest that UC and CD represent related, complex genetic diseases. Associations with genetic syndromes and autoimmune disorders, which have a known genetic component, further support this concept. 5 Genome-wide linkage scans have identified a number of susceptibility loci suggesting that several genes are associated with IBD. [6] [7] [8] [9] Some of these loci appear to be common to both CD and UC while others are unique to either disease. Such genetic complexity is postulated to arise from epistasis (gene-gene interactions) and from gene-environment interactions. 9, 10 Individual case-control association studies have demonstrated significant associations with particular alleles in a number of candidate genes although lack of reproducibility may further suggest genetic heterogeneity. Cytokines have been implicated in the pathogenesis of chronic inflammatory diseases and have a regulatory and effector role in the mucosal immune and inflammatory response in IBD. 11 Interleukin-1 (IL-1) alpha and beta are major proinflammatory cytokines involved early in the inflammatory cascade. The interleukin-1 receptor antagonist (IL-1ra) is the inhibitor of these IL-1 agonists and acts by competitively binding to IL-1 receptors without eliciting signal transduction. 12 All three proteins are coded by genes in the interleukin-1 gene cluster on the long arm of chromosome 2. 13 Enhanced production of IL-1 has been shown in the gut tissue of animal models of intestinal inflammation 14, 15 and in both the colonic mucosa 16 and by cell preparations isolated from the intestine of patients with IBD. 17 Tissue levels correlate with disease activity but the IL-1ra/IL-1 ratio shows the closest correlation with inflammation. 18 Rabbit immune complex colitis is attenuated by the administration of IL-1ra 19 and reduction of IL-1ra levels by either gene knockout in mice 20 or by antibody neutralisation in rabbits 21 increases susceptibility to the induction of colitis. An imbalance in the IL-1ra/IL-1 ratio may therefore contribute to the chronic inflammatory response in ulcerative colitis. The molecular mechanisms underlying this imbalance in IBD are unknown. However, interindividual differences in cytokine production may be under genetic control. 22 The IL-1 gene cluster contains several polymorphic genetic markers. The IL-1ra gene (IL-1RN) contains a variable number of tandem repeats (VNTR) polymorphism in intron 2, 23 which is in complete linkage disequilibrium with a single-nucleotide polymorphism (SNP) in exon 2 ( þ 2018). 24, 25 SNPs have also been identified in both the IL-1 beta (IL-1B) and the IL-1a genes (IL-1A). 26 The variable degree of linkage disequilibrium that exists across the gene cluster between these markers has recently been studied in detail. 27 Polymorphisms within the IL-1 gene cluster have been associated with both susceptibility to and severity of a number of chronic inflammatory and autoimmune conditions. 26 Allele 2 of the IL-1RN VNTR polymorphism (IL-1RNn 2) was first reported to be associated with UC in 1994. 28 Although not all subsequent studies in Caucasian Northern European patients have confirmed this association [29] [30] [31] [32] [33] [34] their lack of statistical significance could reflect inadequate power. This was supported by the significant association found in a further wellpowered study and an accompanying meta-analysis of this and the seven previous studies in Caucasian North European patients. 25 Two subsequent studies have been performed in Northern European populations. One of these studies confirmed the association 35 while the other did not. 36 A further study did confirm the genetic association in Jewish and Hispanic populations. 37 The association appears to be greatest in patients with extensive disease and in those requiring surgery for UC. 32, 38 Allelic associations of SNPs within the IL-1A and IL-1B with IBD have not been demonstrated, although this may represent the limited power of these studies. 28, 32, 34, 39 However, a recent study did suggest that the IL-1B þ 3954 polymorphism might have a role in determining disease behavior. 40 To further investigate the previously described genetic association with UC, the functional effect of the IL-1RNn2 and other polymorphic variants within the IL-1 gene cluster have been examined in terms of steady-state protein and mRNA expression in vivo in the colonic mucosa.
Results
Patient characteristics/IL-1 gene cluster SNP genotypes Table 1 shows the IL-1RN ( þ 2018), IL-1B (À511 and þ 3954) and IL-1A ( þ 4845) genotypes for the noninflamed controls and UC patients, studied. In this small cohort of patients, no statistical differences in allele carriage rates or allelic frequencies were demonstrated although a trend was evident for IL-1RN, with carriage of the allele 2 increased in patients with UC compared to controls was observed (53 vs 39%) as expected. These patients were genotyped as part of a large study assessing the role of the IL-1RN in genetic susceptibility to UC. 25 Cytokine concentrations in colitis vs normals Table 2 shows the tissue cytokine levels (normalised for DNA content) of biopsies from UC and control patients. The tissue levels of IL-1a and IL-1b were low in the control biopsy specimens. Total IL-1b tissue levels were approximately 5-10 fold higher than the IL-1a levels. IL1ra tissue levels were approximately 1000 fold higher than total IL-1 levels in biopsies from controls. The IL-1a, IL-1b and IL-1ra tissue levels were all increased in rectal biopsy samples from patients with UC compared to controls. The IL-1ra/IL-1 ratio in the mucosa was decreased in UC patients compared to the controls. Colonic mucosal levels of IL-1 alpha, IL-1 beta, IL-1ra and IL-1ra/ total IL-1 ratio of biopsies from UC and noninflammatory control patients. Data are shown as mean (7SEM). Cytokine concentrations are normalised for DNA content of the homogenate (to normalise for cell number). Cytokine concentrations and DNA content of tissue homogenates were measured using ELISA and a novel fluorescent nucleic acid stain, Picogreen s respectively, as described in Materials and methods. Using stepwise linear logistic regression as described in Statistical methods, diagnosis of UC was independently significantly associated with IL-1a (P¼0.008), IL-1b (Po0.0001) and IL-1ra (Po0.0001) colonic protein levels. The IL1ra/total IL-1ra level was not significantly reduced in the colonic mucosa in patients with UC compared to noninflammatory controls (P40.05) after degree of inflammation and IL-1RN genotype were accounted for by the regression analysis.
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Factors determining colonic cytokine concentrations Linear regression analyses were performed in a stepwise fashion. Three variables were significant for inclusion in the linear regression model for colonic IL-1ra level. In order of inclusion into the model, these were diagnosis (Po0.0001), IL-1RN genotype (P¼0.001) and treatment (P¼0.03). The proportion of the total variance accounted for by these three variables in the final model was 0.388 (adjusted R 2 0.388; Po 0.0001). Figure 1 shows the tissue IL-1ra levels in (a) UC patients and (b) control patients according to the IL-1RN genotype. Carriage of IL-1RNn2 was associated with reduced protein level with a gene dosage effect. Heterozygous patients had intermediate protein levels while homozygous patients had the lowest levels.
Two variables were significant for inclusion in the linear regression model for colonic IL-1ra/total IL-1 ratio. In order of inclusion into the model, these were macroscopic inflammatory activity (Po0.0001) and IL-1RN genotype (P¼0.005). The final model had an adjusted R 2 of 0.253 (Po0.0001). Figure 2 shows the tissue IL-1ra/total IL-1 ratio in (a) UC patients and (b) control patients according to the IL-1RN genotype. Carriage of IL-1RNn 2 was associated with a reduced IL-1ra/total IL-1 ratio with a gene-dosage relationship.
Three variables were significant for inclusion in the linear regression model for colonic IL-1a protein level. In order of inclusion into the model, these were histological inflammatory grade (P¼0.002), diagnosis (P¼0.008) and macroscopic inflammatory grade (P¼0.023). The final model had an adjusted R 2 of 0.498 (Po0.0001). Variables for IL-1A, IL-1B or IL-1RN genotypes were not significant and were not included in the model. Three variables were significant for inclusion in the linear regression model for colonic IL-1b protein level. In order of inclusion into the model, these were diagnosis (Po0.0001), histological inflammatory grade (P¼0.007) and macroscopic inflammatory grade (P¼0.02). The final model had an adjusted R 2 0.565 (Po0.0001). Variables for IL-1A, IL-1B or IL-1RN genotypes were not significant and were not included in the model.
Ratio of allele 1/allele 2 mRNA in heterozygous patient colonic mucosa Figure 3 shows a composite phosphor-imaging gel of the allele-specific transcript analysis for the seven UC patients who were heterozygous for the þ 2018 IL-1RN polymorphism. The ratio of allele 1 mRNA/allele 2 mRNA was significantly greater than 1 in all cases (P¼0.018), ranging from 1.2 to 3.1. Allele 2 was consistently associated with lower accumulation of IL-1ra mRNA than allele 1.
Discussion
We have studied the functional correlates of polymorphisms within the IL-1 gene cluster in the colonic mucosa in vivo, to investigate whether the observed genetic association between the rarer allele of the IL-1RN and UC is Figure 1 Colonic mucosal levels of IL-1ra according to IL-1RN genotype. Data are shown as mean (7s.e.m.). Cytokine concentrations are normalised for DNA content of the homogenate (to normalise for cell number). Cytokine concentrations and DNA content of tissue homogenates were measured using ELISA and a novel fluorescent nucleic acid stain, Picogreen s respectively, as described in Materials and methods. IL-1RN genotypes were determined using PCR and restriction enzyme analysis as described in Materials and methods. Using stepwise linear logistic regression as described in Statistical methods the IL-1 RN genotype was independently significantly associated with colonic IL-1ra protein level (P¼0.001). .e.m.). Cytokine concentrations are normalised for DNA content of the homogenate (to normalise for cell number). Cytokine concentrations and DNA content of tissue homogenates were measured using ELISA and a novel fluorescent nucleic acid stain, Picogreen s respectively, as described in Materials and methods. IL-1RN genotypes were determined using PCR and restriction enzyme analysis as described in Materials and methods. Using stepwise linear logistic regression as described in Statistical methods the IL-1RN genotype was independently significantly associated with the colonic IL-1ra/total IL-1 ratio (P¼0.005).
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MJ Carter et al reflected in functional differences of the genes in the patient population. The results presented here show that the rarer allele of the IL-1RN is associated with reduced accumulation of IL-1ra protein within the colonic mucosa, and is also associated with a significant reduction in the biologically important IL-1ra/total IL-1 ratio. Using a allele-specific transcript analysis methodology in heterozygous individuals with UC, we have further demonstrated that the rarer allele is associated with less steady-state mRNA within the colonic mucosa compared to the more common allele. This functional association for the disease-related allele provides a biologically plausible explanation for the association between the allele and UC as the reduced IL-1ra and concomitant IL-1ra/IL-1 ratio may prevent adequate control of mucosal inflammation.
The results presented also demonstrate that the wellcharacterised polymorphisms within the IL-1A and IL-1B do not appear to be associated with a functional effect in terms of their respective cytokine expression in the colonic mucosa. This may provide an explanation for the lack of association between these polymorphisms and ulcerative colitis in previous case-control association studies. 28, 32, 34, 39 The results presented here also provide further data assessing factors that are associated with cytokine levels in the colonic mucosa. Patients with ulcerative colitis had higher colonic levels of IL-1ra, IL-1a and IL-1b compared to healthy controls and disease status was shown to be an independent predictor of these protein levels, which concurs with previous data. 16, 18, 41, 42 Inflammation is associated with marked rises in colonic levels of proinflammatory cytokines IL-1a and IL-1b which are normally expressed at low levels. IL-1ra is a constitutively expressed cytokine and although levels rise with inflammation, we have not demonstrated this to be independent of the diagnosis of ulcerative colitis and IL-1RA genotype. 18, 41, 42 We did not demonstrate the previous observation that IBD was an independent predictor of the IL-1ra/total IL-1 ratio. 18, 41, 42 However, these previous studies did not take genotypic effects in to consideration which may provide an explanation for these contrasting results. Although our patients with UC had a lower IL-1ra/IL-1 ratio than noninflammatory patients this was not demonstrated to be independent of the degree of inflammation and IL-1RN genotype. The IL-1ra/total IL-1 ratio was however demonstrated to be very highly associated with the degree of inflammation as reported previously.
Previous data regarding the functional effects of the IL-1RN polymorphism on IL-1ra and IL-1 production are conflicting. The rarer allele 2 of the IL-1RN has been associated with both increased and decreased IL-1ra protein production from peripheral blood mononuclear cells (PBMC) in vitro. 43, 37 The investigators however used different stimuli to elicit IL-1ra protein production from the PBMC which makes direct comparison difficult. The effect of IL-1RNn2 on serum levels of IL-1ra has also been assessed in healthy controls and was shown to correlate with increased plasma levels of the protein with some coordinate regulation supplied by the IL-1beta gene. 44 A further small study in diabetic patients demonstrated similar findings but was unable to confirm the findings in healthy controls. 45 However, serum IL-1ra is an acute-phase protein 46 and regulation of serum levels may be under different control pathways compared to local tissue levels such as the colonic mucosa.
A single study has investigated protein expression in the colonic mucosa and suggested that total IL-1ra protein was reduced in individuals who carried at least one copy of the IL-1RNn2. 47 Results from this previous study represented a combination of patients with UC, CD, inflammatory controls and noninflamed controls. Our results support and extend this later study's findings by demonstrating a significant functional effect of the IL-1RNn2 in the colonic mucosa. We have also demonstrated that the allele 2 is also associated with a reduction in the biologically important ratio of IL-1ra/ total IL-1. In addition, we have shown that the decreased protein expression is associated with a decreased steady-state mRNA level. In lane 3, the sample is digested with MspI, the upper band (a) represents cDNA from mRNA transcribed from allele 1, and the lower band (b) being related to allele 2. Following quantitation of each band by phosphor-imaging, the allele 1/allele 2-derived cDNA ratio by both digestions is shown (c). The average ratio for each patient is also shown (d).
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There are conflicting data regarding the functional effect of the IL-1 beta polymorphisms on IL-1 beta production. 48, 49 Indeed, Santtilla's 48 study suggest that the IL-1RNn2 or an unknown allele strongly associated with it has a more major role in vitro IL-1 beta production. There are no data on the quantitative functional correlates of the IL-1 alpha polymorphism although it results in protein dimorphism (serine for alanine at 114). In this study, in vivo in the colonic mucosa we have been unable to demonstrate any functional correlates of these polymorphisms.
The VNTR polymorphism is in a noncoding region of the gene in intron 2 and the exon 2 polymorphism is a conservative base-pair change which does not alter the protein amino-acid sequence. It is difficult to envisage how either polymorphism has a direct functional effect in terms of IL-1ra production and indeed unpublished gene reporter studies showed that the VNTR itself had no effect on gene transcription in vivo (JK Tarlow, personal communication). It is therefore likely that both polymorphisms are in linkage disequilibrium with a functional polymorphism, as yet undefined. This functional genetic change is perhaps most likely to be either in the gene promoter region or in the 3 0 untranslated region, affecting gene transcription or post-transcriptional events, respectively. Whether this reduced mRNA level is due to decreased transcription or decreased mRNA stability is under further investigation. Positive results in either sense will focus study on the putative promoter regions or 3 0 UTR of the IL-1RN where functional variants in linkage with the IL-1RN allele may be sought.
The results presented therefore demonstrate that the IL-1RNn 2 correlates with reduced levels of IL-1ra protein and mRNA in the colonic mucosa providing a biologically plausible explanation for the observed association of the allele with ulcerative colitis. Future work will involve the characterisation of DNA structures in the IL-1 cluster that are responsible for this functional association, and the use of this information to develop new therapies including pharmacogenetic approaches.
Materials and methods

Patients and controls
This study was approved by the South Sheffield Local Research Ethics Committee in 1994 and was performed in accordance with the Declaration of Helsinki. All patients participated in the study after giving fully informed written consent.
A total of 99 patients with UC were studied. Disease diagnosis had been confirmed by colonoscopy with colonic series of biopsies in all patients within 4 years of entry into the study. Patients were included only if histological assessment was suggestive, highly suggestive or diagnostic of UC as outlined in the British Society of Gastroenterology guidelines. 50 Individuals with histological appearances of indeterminate chronic inflammatory bowel disease or Crohn's disease were excluded. The histological limit of inflammation was used to define disease extent which was classified as either extensive or nonextensive depending on whether the inflammation extended beyond the splenic flexure. Clinical details including sex, age at diagnosis, age at biopsy, extent of colitis, current medication, family history of UC and IBD were collected prospectively at the time of sampling. In all, 17 patients were taking corticosteroids, 59 were taking 5-aminosalicylic acid drugs, 14 were taking azathioprine and 28 were on no medication at the time of sampling colonic tissue. Median age at diagnosis was 31 years (range 8-75) and median age at biopsy was 41 years (range 17-82). 63 patients had nonextensive disease, 52 were female and 14 had a family history of IBD (first-or second-degree relative).
Healthy controls who were undergoing colonoscopy for investigation of noninflammatory conditions (n¼54) were also studied. The absence of colonic inflammation in these patients was confirmed by histological examination of a separate rectal biopsy taken at the same time as those taken for assay of cytokine concentrations. Of these patients 32 were female and 22 were male. Median age at biopsy was 53 years (range 23-85). Indication for colonoscopy was; 14 polyp surveillance, 10 per rectum bleeding, eight altered bowel habit, seven polyp excision, seven iron deficiency anaemia, four abdominal pain, two colonic carcinoma follow-up, one constipation and one angiodysplasia.
Genotyping for IL-1 gene cluster polymorphisms Blood was taken into ethylenediamine-tetraacetic acid (EDTA) tubes (2 Â 10 ml) and stored frozen until DNA was extracted by standard methods. 26 DNA was stored at 41C. Genotyping was performed using PCR and restriction enzyme digestion and gel electrophoresis. All patients were genotyped for the C/T IL-1RN SNP at position þ 2018 as previously described, 26 a marker which is in 100% linkage disequilibrium with the IL-1RN VNTR polymorphism. 25 All patients were also genotyped for the two C/T SNPs in the IL-1 beta gene at positions À511 and þ 3954, and for the C/T IL-1 alpha SNP at position þ 4845, as previously described. 26 Negative controls were included with each reaction.
Biopsy specimens
Endoscopic biopsy specimens were obtained during colonoscopy. All specimens were taken from the rectum at approximately 10 cm from the anal margin to ensure uniformity. Three biopsies were taken during endoscopic examination for cytokine assay and a further sample for histopathology. The degree of inflammation at the biopsy site was graded macroscopically by a gastroenterologist according to the Baron grade 51 and microscopically by a single gastroenterological histopathologist. 52 Biopsies for cytokine analysis were immediately frozen in liquid nitrogen before being transferred to a freezer for storage at À701C prior to homogenization. Biopsies for histological examination were formalin fixed and stained by standard methods with haematoxylin and eosin.
Assay of cytokine concentrations
Biopsy specimens for assay of cytokine concentrations and DNA content were homogenised on ice in 750 ml of PBS pH 7.2 in the presence of proteinase inhibitor (Cocktail Protease Inhibitor, Roche, UK) using a pestle and mortar mechanical homogeniser on ice. Insoluble material was centrifuged at 10 000 g (Beckman J6, USA) at 41C for 15 min. To avoid repeated freeze thawing, tissue homogenate was divided into separate aliquots for assay of each cytokine and for DNA content, and were stored at À701C prior to use.
Aliquots of the tissue supernatant were used for the determination of IL-1ra, IL-1a and IL-1b by ELISA (R&D Systems, Minneapolis, MN, USA). Where protein concentrations exceeded the limit of detection of the assays, concentrations were assayed in appropriate dilutions of the tissue homogenate. Total IL-1 agonist concentration was made by addition of IL-1a and IL-1b concentrations. In order to avoid bias for cellularity due to confounding elements in the extracellular matrix and the presence of oedema, when there are variable degrees of inflammation, we normalised cytokine concentrations to total DNA content, a method previously used in chronic inflammatory arthritis 53 and IBD. 54 Assay of DNA content of colonic biopsy specimens Aliquots of the soluble supernatant were used for the determination of DNA content. DNA content was assayed using a novel fluorescent nucleic acid stain, Picogreen s (PicoGreent, Molecular Probes, Leiden) that selectively binds double-stranded DNA and provides accurate estimates in complex solutions. 55 DNA content of tissue homogenates was assayed using a LS50B scanning fluorimeter (Perkin-Elmer, Warrington, UK). Fluorescein excitation and emission wavelengths of samples were compared to DNA standard curves and values obtained by interpolation. All tissue homogenates were assayed in triplicate.
Allele-specific transcript analysis (ASTA)
The IL-1RN þ 2018 polymorphism was used as an exonic marker to recognise mRNA copies that had been transcribed from either allele of the IL-1RN gene, using a previously described method of allele-specific transcript analysis developed in our laboratory. 24 This method has recently been revisited and validated. 56 Rectal mucosal biopsies were obtained from seven patients with UC who were heterozygous for the SNP (C/T at þ 2018) in exon 2 of the IL-1RN gene. Biopsies were taken as described above but were stored in liquid nitrogen until homogenisation. Total cellular RNA was extracted after tissue homogenisation on dry ice using a modification of the acid guanidinium-phenol-chloroform method (RNAzol; Biogenesis). 57 Approximately 1 mg RNA was reverse-transcribed with random hexamers and AMV reverse transcriptase (Promega) in a final reaction volume of 10 ml at 421C for 1 h. This cDNA was then subjected to PCR with a forward primer 5 0 -TTC.TAT.CTG.AGG.AAC.AAC.CAA.CTA. GTA.GC-3 0 adjoining the polymorphic site and reverse primer 5 0 -CAC.CAG.ACT.TGA.CAC.AGG.ACA.GGC. ACA.TC-3 0 . The forward primer contained a single-base mis-match two bases from the 3' end that creates a restriction site for AluI in allele 1 of the exon 2 polymorphism (AG 3 CTGG). The disease-associated allele 2 itself completes a restriction site for MspI. After 28 cycles of PCR excess 32 P-end-labelled reverse primer was added and allowed to anneal. Data from optimisation experiments suggested us to use 28 cycles of PCR to ensure suboptimal cycling so that products had not reached plateau phase (data not shown). The radioactive reverse primer (added at the start of the last PCR cycle) was then extended for 5 min at 721. Thus, the only radioactive products were from the final extension and were not likely to be heteroduplexed and subsequently resistant to restriction digestion.
PCR products of 154 bp were divided and allelespecific restriction digestion performed using restriction enzymes AluI and MspI. Digested products were electrophoresed on 9% polyacrylamide gels which were then dried and analysed on a Biorad G-250 molecular imager. MspI digestion of heterozygous cDNA gave fragments of 154 bp (labelled) corresponding to allele 1 (uncleaved) and 125 bp (labelled) and 29 bp (unlabelled) from allele 2. AluI digestion of heterozygous cDNA gave fragments of 154 bp (labelled) corresponding to allele 2 (uncleaved) and 126 bp (labelled) and 28 bp (unlabelled) from allele 1.
Radioactive RT-PCR products were quantified by measuring the density of phosphor-imager units in each band, and after subtraction of background, these results were used to calculate the relative amounts of mRNA derived from each allele. Such analysis accounted for confounding factors such as interindividual variability and loading and/or pipetting errors. Moreover, by using restriction enzymes specific for each allele, the ratio was measured in two opposite ways simultaneously in the same patient, providing an internal control. Experiments were repeated three times in all seven individuals from the initial RNA preparation.
Statistical methods
Allelic carriage rates were compared between cases and controls using w 2 statistics. To analyse which factors were associated with the individual cytokine levels and the IL1ra/total IL-1 ratio, a multiple stepwise linear regression was performed. Natural logarithms of cytokine concentrations and the IL-1ra/Total IL-1 ratio were entered as the dependent variable. Factors included in all the analyses were diagnosis (UC or control), histological inflammatory grade (0-9), macroscopic inflammatory grade (0-3), treatment with anti-inflammatory medication (yes or no), sex (male or female) and genotypes (1,1, 1,2 and 2,2) of the four single-nucleotide polymorphisms. For the allele-specific transcript analysis, the ratio of allele 1 mRNA to allele 2 mRNA was compared using the Wilcoxon signed-rank test for paired data.
